Pulse Study: Peripheral Use of Low-dose Vasopressors for Safety and Efficacy in the Intensive Care Unit

PHASE2RecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

February 3, 2025

Primary Completion Date

December 30, 2025

Study Completion Date

June 30, 2026

Conditions
ShockPeripheral Venous CatheterizationCentral Venous CatheterizationCritically Ill Patients Admitted in ICU
Interventions
PROCEDURE

Experiemental: Peripheral Venous Catheter

Patients older than 18 years of age who present with shock requiring vasopressors at the following minimum doses: norepinephrine 5 mcg/min, phenylephrine 50 mcg/min, epinephrine 5 mc/min, dobutamine 5 mcg/kg/min. Vasopressors are infused through a peripheral venous catheter (18 gauge or larger); however, patients are crossed over to the central venous catheter group if the maximum vasopressor dose is reached or more than two vasopressors.

Trial Locations (1)

K7K 2V7

RECRUITING

Kingston Health Sciences Center, Kingston

All Listed Sponsors
lead

Kingston Health Sciences Centre

OTHER